Dual-responsive nanoparticles for enhanced drug delivery in breast Cancer chemotherapy

被引:3
作者
Ren, Yuxin [1 ,2 ]
Li, Peishan [1 ,2 ]
Xie, Ying [1 ,2 ]
Xu, Jiarui [1 ,2 ]
Luo, Qian [1 ,2 ]
Chen, Ming [1 ,2 ]
Liu, Rui [1 ,2 ]
Feng, Hexuan [1 ,2 ]
Chen, Yuling [1 ,2 ]
Liu, Yixuan [1 ,2 ]
Bao, Chunjie [1 ,2 ]
Duan, Jialun [1 ,2 ]
Li, Jianwei [1 ,2 ,3 ,4 ]
Lu, Wanliang [1 ,2 ]
机构
[1] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing Key Lab Mol Pharmaceut & New Drug Delivery, Beijing, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[3] Changzhi Med Coll, Sch Pharm, Changzhi 046000, Peoples R China
[4] Beijing Zhendong Guangming Pharmaceut Res Inst Co, Beijing 100080, Peoples R China
基金
中国国家自然科学基金;
关键词
Dual-responsive nanoparticle; pH responsiveness; Glutathione responsiveness; Deep penetration; Chemotherapy; NANOMEDICINE; MICELLES; CELLS;
D O I
10.1016/j.jconrel.2024.11.026
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug delivery efficiency often affects chemotherapy outcome due to dense collagen barrier in tumor environment. Here, we report a nanoparticle capable of pH and glutathione dual-responsive drug delivery to enhance the efficacy of breast cancer chemotherapy. Maleiminated polyethylene glycol and polylactide block copolymer were synthesized as a core material, doxorubicin was encapsulated into the nanoparticle by self-assembly. Thiocollagenase and maleimide were connected on the nanoparticle surface by click chemistry, and further coated with chondroitin sulfate as a protective layer to form dual-responsive doxorubicin nanoparticle. The results showed that the nanoparticle had the ability to penetrate deep tumor tissue, to target on CD44 of cancer cell, and to release doxorubicin in cancer cell in response to pH and glutathione signals, demonstrating superior anticancer efficacy in breast cancer-bearing mice. In conclusion, the dual-responsive nanoparticle could be used as a drug carrier to enhance drug delivery in breast cancer chemotherapy.
引用
收藏
页码:146 / 161
页数:16
相关论文
共 36 条
[1]   Challenges in liver cancer and possible treatment approaches [J].
Anwanwan, David ;
Singh, Santosh Kumar ;
Singh, Shriti ;
Saikam, Varma ;
Singh, Rajesh .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1873 (01)
[2]   Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery [J].
Borys, Nicholas ;
Dewhirst, Mark W. .
ADVANCED DRUG DELIVERY REVIEWS, 2021, 178
[3]   Glioma stem cells and their roles within the hypoxic tumor microenvironment [J].
Boyd, Nathaniel H. ;
Tran, Anh Nhat ;
Bernstock, Joshua D. ;
Etminan, Tina ;
Jones, Amber B. ;
Gillespie, G. Yancey ;
Friedman, Gregory K. ;
Hjelmeland, Anita B. .
THERANOSTICS, 2021, 11 (02) :665-683
[4]   Self-assembling prodrugs [J].
Cheetham, Andrew G. ;
Chakroun, Rami W. ;
Ma, Wang ;
Cui, Honggang .
CHEMICAL SOCIETY REVIEWS, 2017, 46 (21) :6638-6663
[5]   Breast Cancer Statistics, 2013 [J].
DeSantis, Carol ;
Ma, Jiemin ;
Bryan, Leah ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (01) :52-62
[6]   Mechanisms of Endocytosis [J].
Doherty, Gary J. ;
McMahon, Harvey T. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :857-902
[7]   Impact of Nanotechnology on Drug Delivery [J].
Farokhzad, Omid C. ;
Langer, Robert .
ACS NANO, 2009, 3 (01) :16-20
[8]  
Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]
[9]   Mitochondria-Targeted Cancer Therapy Using a Light-Up Probe with Aggregation-Induced-Emission Characteristics [J].
Hu, Qinglian ;
Gao, Meng ;
Feng, Guangxue ;
Liu, Bin .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (51) :14225-14229
[10]   Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy [J].
Jia, Xiaobo ;
Zhang, Yihua ;
Zou, Yu ;
Wang, Yao ;
Niu, Dechao ;
He, Qianjun ;
Huang, Zhangjian ;
Zhu, Weihong ;
Tian, He ;
Shi, Jianlin ;
Li, Yongsheng .
ADVANCED MATERIALS, 2018, 30 (30)